mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.4 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.4 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.4 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.4 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.4 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.4 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.4 |